Trial
NCT03432897
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
Rhode Island Hospital; The Miriam Hospital; AstraZeneca
Condition
Prostate Cancer
Intervention
Olaparib Pill
Why stopped
Lack of enrollment secondary to eligibility criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-08